ERROR! No headcode.htm file found.

School of Medicine


Showing 301-400 of 468 Results

  • Arogyaswami Paulraj

    Arogyaswami Paulraj

    Professor (Research) of Electrical Engineering, Emeritus

    Bio Professor Emeritus Arogyaswami Paulraj, Stanford University, is a pioneer of MIMO wireless communications, a technology break through that enables improved wireless performance. MIMO is now incorporated into all new wireless systems.

    Paulraj is the author of over 400 research papers, two textbooks, and a co-inventor in 80 US patents.

    Paulraj has won over a dozen awards, notably the National Inventors Hall of Fame (USPTO), Marconi Prize and Fellowship, 2014 and the IEEE Alexander Graham Bell Medal, 2011. He is a fellow of eight scientific / engineering national academies including the US, China, India, and Sweden. He is a fellow of IEEE and AAAS.

    In 1999, Paulraj founded Iospan Wireless Inc. - which developed and established MIMO-OFDMA wireless as the core 4G technology. Iospan was acquired by Intel Corporation in 2003. In 2004, he co-founded Beceem Communications Inc. The company became the market leader in 4G-WiMAX semiconductor and was acquired by Broadcom Corp. in 2010. In 2014 he founded Rasa Networks to develop Machine Learning tools for WiFi Networks. The company was acquired HPE in 2016.

    During his 30 years in the Indian (Navy) (1961-1991), he founded three national-level laboratories in India and headed one of India?s most successful military R&D projects ? APSOH sonar. He received over a dozen awards (many at the national level) in India including the Padma Bhushan, Ati Vishist Seva Medal and the VASVIK Medal.

  • John M. Pauly

    John M. Pauly

    Reid Weaver Dennis Professor

    Bio Interests include medical imaging generally, and magnetic resonance imaging (MRI) in particular. Current efforts are focused on medical applications of MRI where real-time interactive imaging is important. Two examples are cardiac imaging, and the interactive guidance of interventional procedures. Specific interests include rapid methods for the excitation and acquisition of the MR signal, and the reconstruction of images from the data acquired using these approaches.

  • Ronald Pearl

    Ronald Pearl

    Dr. Richard K. and Erika N. Richards Professor

    Current Research and Scholarly Interests Mechanims (molecular and cellular) of pulmonary hypertension, treatment of pulmonary hypertension, treatment of respiratory failure, treatment of septic shock, hemodynamic monitoring

  • Norbert Pelc

    Norbert Pelc

    Boston Scientific Applied Biomedical Engineering Professor and Professor of Radiology, Emeritus

    Current Research and Scholarly Interests Broadly, Dr. Pelc is interested in the physics, engineering and mathematics of medical imaging, especially computed tomography, digital x-ray imaging, magnetic resonance imaging, and hybrid multimodality systems. His current research is concentrated in the development of computed tomography systems with higher image quality and dose efficiency, in the characterization of system performance, and in the development and validation of new clinical applications.

  • Marco Perez

    Marco Perez

    Associate Professor of Medicine (Cardiovascular Medicine)

    Bio Dr. Marco Perez's research goal is to better understand the fundamental causes of cardiovascular disease through the study of genetics and epidemiology. His group studies the genetic variations and environmental exposures that are associated with conditions such as atrial fibrillation and heart failure. He has led the studies of atrial fibrillation in Women's Health Initiative, one of the largest nation-wide population-based cohorts. He is currently conducting a large study monitoring for silent or asymptomatic atrial fibrillation in women from the WHI randomized to exercise intervention, and is co-PI in the Apple Heart Study, a clinical trial using the Apple Watch to screen for atrial fibrillation. He is interested in understanding the paradox that atrial fibrillation is less common in African Americans and Hispanics, despite a greater burden of risk factors such as hypertension. As director of the Stanford Inherited Arrhythmia Clinic, he evaluates families with rare inherited arrhythmias associated with sudden death such as Long QT and Brugada Syndromes and explores their links with novel genes. He is particularly interested in studying the genetic causes of very early onset atrial fibrillation. He also studies how best to use the electrocardiogram to identify patients at risk for atrial fibrillation and athletes at risk for life-threatening arrhythmias due to conditions such as hypertrophic cardiomyopathy. His genetic studies have led to the discovery of promising novel therapeutic targets that his group is now studying at a functional level. Dr. Perez receives funding from NIH/NHLBI (R01), Apple Inc., the Weston Havens Foundation, The Stanford Cardiovascular Division and the Stanford SPARK program.

  • Mark Perlroth, MD

    Mark Perlroth, MD

    Professor (Clinical) of Medicine, Emeritus

    Current Research and Scholarly Interests 1. Adult Congenital Heart Disease
    2. Cardiac Transplantation
    3. General Cardiology
    4. Porphyrias

  • Ada Poon

    Ada Poon

    Associate Professor of Electrical Engineering

    Current Research and Scholarly Interests Our research focuses on providing theoretical foundations and engineering platforms for realizing electronics that seamlessly integrate with the body. Such systems will allow precise recording or modulation of physiological activity, for advancing basic scientific discovery and for restoring or augmenting biological functions for clinical applications.

  • Richard Popp

    Richard Popp

    Professor of Medicine (Cardiovascular Medicine), Emeritus

    Current Research and Scholarly Interests Academic-Industrial relations; Ethics of invention.

  • Matthew Porteus

    Matthew Porteus

    Sutardja Chuk Professor of Definitive and Curative Medicine

    Bio Dr. Porteus was raised in California and was a local graduate of Gunn High School before completing A.B. degree in ?History and Science? at Harvard University where he graduated Magna Cum Laude and wrote an thesis entitled ?Safe or Dangerous Chimeras: The recombinant DNA controversy as a conflict between differing socially constructed interpretations of recombinant DNA technology.? He then returned to the area and completed his combined MD, PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development with his PhD thesis entitled ?Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development.? After completion of his dual degree program, he was an intern and resident in Pediatrics at Boston Children?s Hospital and then completed his Pediatric Hematology/Oncology fellowship in the combined Boston Chidlren?s Hospital/Dana Farber Cancer Institute program. For his fellowship and post-doctoral research he worked with Dr. David Baltimore at MIT and CalTech where he began his studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Following his training with Dr. Baltimore, he took an independent faculty position at UT Southwestern in the Departments of Pediatrics and Biochemistry before again returning to Stanford in 2010 as an Associate Professor. During this time his work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and is considered one of the pioneers and founders of the field of genome editing?a field that now encompasses thousands of labs and several new companies throughout the world. His research program continues to focus on developing genome editing by homologous recombination as curative therapy for children with genetic diseases but also has interests in the clonal dynamics of heterogeneous populations and the use of genome editing to better understand diseases that affect children including infant leukemias and genetic diseases that affect the muscle. Clinically, Dr. Porteus attends at the Lucille Packard Children?s Hospital where he takes care of pediatric patients undergoing hematopoietic stem cell transplantation.

  • Guillem Pratx

    Guillem Pratx

    Associate Professor of Radiation Oncology (Radiation Physics)

    Current Research and Scholarly Interests The Physical Oncology Lab is interested in making a lasting impact on translational cancer research by building novel physical tools and methods.

  • James Priest

    James Priest

    Adjunct Clinical Assistant Professor, Pediatrics - Cardiology

    Current Research and Scholarly Interests The Priest lab seeks a better understanding of the genetics and pathogenesis of congenital heart disease using translational genomics, big-data, and vertebrate models of cardiac development.

  • Stephen Quake

    Stephen Quake

    Lee Otterson Professor in the School of Engineering and Professor of Bioengineering, of Applied Physics and, by courtesy, of Physics

    Current Research and Scholarly Interests Single molecule biophysics, precision force measurement, micro and nano fabrication with soft materials, integrated microfluidics and large scale biological automation.

  • Thomas Quertermous, MD

    Thomas Quertermous, MD

    William G. Irwin Professor of Cardiovascular Medicine

    Current Research and Scholarly Interests Understanding genetic basis of cardiovascular function and disease.

  • James Quinn

    James Quinn

    Professor of Emergency Medicine

    Current Research and Scholarly Interests Dr. Quinn's primary focus is emergency care research with previous experience running large multi-center trials.. He has an extensive research background in clinical decision making involving patients with syncope and in the development and clinical evaluation of tissue adhesives. He is currently focused on the use of machine learning and artificial intelligence algorithms to augment physician decision making and personalizing the care of patients.

  • Marlene Rabinovitch

    Marlene Rabinovitch

    Dwight and Vera Dunlevie Professor of Pediatric Cardiology

    Current Research and Scholarly Interests Our research program seeks to identify the cellular and molecular programs regulating vascular and lung development, through the use of cultured cells and tissues and mouse and rat models. We then determine how these programs are perturbed by genetic abnormalities or injurious processes associated with disease, focusing on pulmonary arterial hypertension (PAH), a fatal complication in children with heart defects, and a condition of unknown etiology primarily in young women.

  • Ralph Rabkin

    Ralph Rabkin

    Professor of Medicine, Emeritus

    Current Research and Scholarly Interests Dr Rabkin is examining the mechanism of the acquired resistance to hormones that develops in kidney failure.In particular he is studying the impact of kidney failure on the action of growth hormone and the role of impaired signal transduction as a cause of growth hormone resistance. He is also engaged in the study of growth factors in diabetic kidney disease.

  • Thomas Raffin

    Thomas Raffin

    The Colleen and Robert Haas Professor in Medicine and Biomedical Ethics, Emeritus

    Current Research and Scholarly Interests Dr. Raffin is a clinician, teacher and investigator. He retired as Chief of the Division of Pulmonary and Critical Care Medicine in 2004. His key areas of academic interest include the biology and management of acute lung injury; basic biology of human lung and white cells; and, key issues in biomedical ethics including withholding and withdrawing life support, health care delivery, genomics, genetic screening, and neuroethics.

  • Chandra Ramamoorthy

    Chandra Ramamoorthy

    Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric)

    Current Research and Scholarly Interests Neuro protection and neurologic outcomes in cardiac patients prior to and concurrent with cardiac surgery and catheterization

  • Thomas Rando, MD, PhD

    Thomas Rando, MD, PhD

    Professor of Neurology

    Current Research and Scholarly Interests Our laboratory studies the molecular mechanisms regulating stem cell function, the effects of aging on skeletal muscle and skeletal muscle stem cells, and the pathogenesis and experimental therapeutics for hereditary muscle diseases, specifically the muscular dystrophies.

  • Anoop Rao

    Anoop Rao

    Clinical Assistant Professor, Pediatrics - Neonatal and Developmental Medicine

    Current Research and Scholarly Interests Wearable senors, unobtrusive vital sign monitoring, natural language processing/text mining

  • Natalie L. Rasgon

    Natalie L. Rasgon

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests Dr. Rasgon has been involved in longitudinal placebo-controlled neuroendocrine studies for nearly two decades, and she has been involved in neuroendocrine and brain imaging studies of estrogen effects on depressed menopausal women for the last eight years. It should be noted that in addition to her duties as a Professor of Psychiatry and Obstetrics & Gynecology, Dr. Rasgon is also the Director of the Behavioral Neuroendocrinology Program and of the Women's Wellness Program.

  • Mohammad Reza Rasouli, MD

    Mohammad Reza Rasouli, MD

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    Bio Dr. Rasouli is a board-certified anesthesiologist specializing in pain management. He practices at Stanford Health Care ? ValleyCare in Pleasanton. He is also a clinical assistant professor in the Stanford University School of Medicine Department of Anesthesiology, Perioperative & Pain Medicine.

    Dr. Rasouli takes pride in developing a comprehensive, compassionate treatment plan personalized to each patient in his care. His goals are to
    relieve patients? chronic pain, and enable them to enjoy the best possible
    quality of life. In addition to his clinical practice, Dr. Rasouli has conducted research and published extensively. He was a postdoctoral research fellow at the Rothman Institute of Orthopaedics at Thomas Jefferson University in Philadelphia.

    Dr. Rasouli has presented the findings of his research at conferences such as the North American Neuromodulation Society Annual Meeting, American Society of Regional Anesthesia and Pain Medicine Meeting, American Society of Anesthesiology Annual Meeting, International Anesthesia Research Society Annual Meeting, and Society of Critical Care Anesthesiologists Annual Meeting. Topics have included using spinal cord and peripheral nerve stimulation for treatment of pain, perioperative pain management, and post-surgical recovery.

    He has published more than 100 articles in the peer-reviewed journals Anesthesiology, Anesthesia and Analgesia, Neurosurgery, Lancet, JAMA, Annals of Surgery, and elsewhere. He also has co-authored chapters in Spine Trauma, Epidemiology of Spinal Cord Injuries, Pain Management Following Total Hip Arthroplasty and Total Knee Arthroplasty, and Epidemiology, Diagnosis and Treatment of Sciatica, and other textbooks.

    Dr. Rasouli has earned numerous honors including the Dr. Jeffrey and Celia Joseph Anesthesiology Scholarly Achievement Award. He is a member of the American Society of Anesthesiologists, California Society of Anesthesiologists, American Society of Regional Anesthesia and Pain Medicine, North American Neuromodulation Society, American Society of Pain and Neuroscience, and Society of Critical Care Medicine.

  • Kristy Red-Horse

    Kristy Red-Horse

    Associate Professor of Biology

    Current Research and Scholarly Interests Cardiovascular developmental biology

  • Olaf Reinhartz

    Olaf Reinhartz

    Associate Professor of Cardiothoracic Surgery

    Current Research and Scholarly Interests 1. Mechanical circulatory support in failing Fontan circulation
    2. Pathophysiologic response to fetal cardiac surgery.
    3. Various clinical projects in pediatric cardiothoracic surgery

  • June-Wha Rhee

    June-Wha Rhee

    Instructor, Cardiovascular Institute

    Bio Dr. Rhee is a general cardiologist with specialized clinical and research training in cardiovascular drug toxicity and pharmacogenomics. She completed clinical cardiology fellowship and internal medicine residency training at Stanford University School of Medicine. During her post-doctoral training, Dr. Rhee's research focused on elucidating cardiotoxic effects of iron overload and of multiple chemotherapeutic agents using patient-specific induced pluripotent stem cells (iPSCs) derived models. Her current research employs clinical data, population genomics, and patient-derived iPSCs models to study genetic determinants and mechanisms of drug-induced cardiovascular toxicities. Dr. Rhee's clinic sees cardio-oncology patients and focuses on devising new methods for minimizing cardiovascular complications in that population.

  • Juan Rivas-Davila

    Juan Rivas-Davila

    Associate Professor of Electrical Engineering and Senior Fellow at the Precourt Institute for Energy

    Current Research and Scholarly Interests Modern applications demand power capabilities beyond what is presently achievable. High performance systems need high power density and bandwidth that are difficult to achieve.
    Power density can be improved with better semiconductors and passive componets, and by reducing the energy storage requirements of the system. By dramatically increasing switching frequency it is possible to reduce size of power converters. I'm interested in high performance/frequency circuits switching >10 MHz.

  • Thomas Robinson

    Thomas Robinson

    The Irving Schulman, M.D. Professor of Child Health, Professor of Medicine (Stanford Prevention Research Center) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly Interests Dr. Robinson originated the solution-oriented research paradigm and directs the Stanford Solutions Science Lab. He is known for his pioneering obesity prevention and treatment research, including the concept of stealth interventions. His research applies social cognitive models of behavior change to behavioral, social, environmental and policy interventions for children and families in real world settings, making the results relevant for informing clinical and public health practice and policy.

  • Stanley G. Rockson, MD

    Stanley G. Rockson, MD

    Allan and Tina Neill Professor of Lymphatic Research and Medicine

    Current Research and Scholarly Interests My clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.

  • Fatima Rodriguez

    Fatima Rodriguez

    Assistant Professor of Medicine (Cardiovascular Medicine)

    Bio Fatima Rodriguez, MD, MPH is an Assistant Professor in Cardiovascular Medicine and (by courtesy) the Stanford Prevention Research Center. She received her MD and MPH from Harvard and completed her cardiovascular fellowship at Stanford. She has expertise in cardiovascular prevention and promoting health equity in cardiovascular care and research. She completed her residency at Brigham and Women's Hospital and a fellowship in Cardiovascular Medicine at Stanford University. She specializes in common cardiac conditions such as coronary artery disease, valvular heart disease, lipid disorders, and cardiovascular risk assessment in high-risk populations.

    Dr. Rodriguez?s research includes a range of topics relating to racial, ethnic, and gender disparities in cardiovascular disease prevention and developing novel interventions to address disparities.

  • Angela Rogers

    Angela Rogers

    Associate Professor of Medicine (Pulmonary and Critical Care)

    Current Research and Scholarly Interests We use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.

  • Rajat Rohatgi

    Rajat Rohatgi

    Associate Professor of Biochemistry and of Medicine (Oncology)

    Current Research and Scholarly Interests the overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.

  • Allyson Rosen, Ph.D.

    Allyson Rosen, Ph.D.

    Clinical Associate Professor (Affiliated) [Vapahcs], Psych/Public Mental Health & Population Sciences

    Bio RESEARCH FOCUS
    Translational cognitive neuroscience of aging and dementia. Neuroethics.

    TRAINING
    Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.

    CLINICAL AND RESEARCH ACTIVITIES
    Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford?s Alzheimer?s Disease Research Center (NIA). Dr. Rosen?s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.

    ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
    Ethics Review
    http://www.j-alz.com/blogs/discussion/protecting-progress

    MIRECC DEMENTIA EDUCATION
    http://www.mirecc.va.gov/visn21/education/dementia_education.asp

  • Glenn Rosen

    Glenn Rosen

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine), Emeritus

    Current Research and Scholarly Interests Our laboratory examines apoptotic and cell signaling pathways in cancer and lung disease. We are studying signaling pathways that regulate oxidative stress responses and cancer cell growth. Part of these studies focus on analysis of non-canonical transcription regulatory functions of the TERC and Tert components of telomerase in lung disease and cancer.

  • David Rosenthal

    David Rosenthal

    Professor of Pediatrics (Pediatric Cardiology)

    Current Research and Scholarly Interests Research interests include the study of Heart Failure, Cardiomyopathy and ventricular dysfunction in children, from a clinical perspective. Investigations include clinical trials of medications, cardiac resynchronization, and mechanical circulatory support.

  • Elsie Gyang Ross

    Elsie Gyang Ross

    Assistant Professor of Surgery (Vascular Surgery) and of Medicine (BMIR)

    Bio Dr. Ross is a vascular surgeon and research scientist. She graduated from Stanford University School of Medicine in 2011 and completed her vascular surgery 0+5 residency at Stanford University School of Medicine in 2018. During her residency, she completed a two-year post-doctoral fellowship in biomedical informatics. Her current research focuses on using machine learning and electronic health records for early disease identification, precision medicine, and evaluating opportunities to engage in patient education beyond the clinic.

  • Stephen J. Roth

    Stephen J. Roth

    Professor of Pediatrics (Cardiology)

    Current Research and Scholarly Interests Randomized Therapeutic Trials in Pediatric Heart Disease, NIH/U01 GrantNo. HL68285 2001-2006.
    Heparin and the Reduction of Thrombosis (HART) Study. Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006.
    A Pilot Trial fo B-type Natriuretic Peptide for Promotion of Urine Output in Diuretic-Resistant Infants Following Cardiovascular Surgery.Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006.

  • Daniel Rubin

    Daniel Rubin

    Professor of Biomedical Data Science and of Radiology (Integrative Biomedical Imaging Informatics at Stanford), of Medicine (Biomedical Informatics Research) and, by courtesy, of Ophthalmology and of Computer Science

    Current Research and Scholarly Interests My research interest is imaging informatics--ways computers can work with images to leverage their rich information content and to help physicians use images to guide personalized care. Work in our lab thus lies at the intersection of biomedical informatics and imaging science.

  • Karim Sallam, MD

    Karim Sallam, MD

    Assistant Professor of Medicine (Cardiovascular Medicine)

    Bio Karim Sallam, MD, is trained in Cardiovascular Medicine and Advanced Heart Failure.

  • Darren Salmi

    Darren Salmi

    Clinical Assistant Professor, Surgery - Anatomy

    Current Research and Scholarly Interests Medical education, anatomy, autopsy, cardiovascular pathology

  • Jacinda Sampson

    Jacinda Sampson

    Clinical Professor, Neurology & Neurological Sciences

    Bio Dr. Jacinda Sampson received her MD and a PhD in biochemistry from University of Alabama at Birmingham, and completed her neurology residency and neurogenetics fellowship at the University of Utah. She served at Columbia University Medical Center prior to joining Stanford University Medical Center in 2015. Her areas of interest include myotonic dystrophies, Duchenne muscular dystrophy, and neurogenetic disorders such as neurofibromatosis, hereditary spastic paraparesis, spinocerebellar ataxia, among others. She is interested in clinical trials for treatment of neurogenetic disorders, and is the clinical application of next-generation genomic sequencing to genetic testing.

  • Nazish Sayed MD, PhD

    Nazish Sayed MD, PhD

    Assistant Professor (Research) of Surgery (Vascular Surgery) and at the Stanford Cardiovascular Institute

    Current Research and Scholarly Interests The Sayed Laboratory is focused on the development of novel technologies that drive innovation in regenerative medicine, disease modeling, and drug testing in vascular biology. The lab conducts translational research in vascular biology and aims to understand the role of the vasculature in the development of cardiac diseases, including those due to inherited genetic variants or environmental insults such as type 2 diabetes or hypertension. The lab employs the human induced pluripotent stem cell (iPSC) technology to generate patient-specific vascular cells (endothelial and vascular smooth muscle cells) as an alternative to animal models providing a human tissue surrogate for research that is scalable and sustainable. By employing this unique platform, the lab also investigates the role of chemotherapeutic agents (anti-cancer drugs) on the vasculature. Dr. Sayed?s lab has also established an endothelial regeneration program, where they leverage the innate immune system to regenerate endothelial cells from human fibroblasts.

    Work from the lab has led to seminal discoveries in the areas of 1) Nitric oxide (NO) biology, (2) vascular biology, (3) stem cell biology, (4) cardiovascular disease modeling (5) cardio-oncology.

  • Erika Schillinger

    Erika Schillinger

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests My passion is clinical skills education: the patient's experience of health and healthcare, doctor-patient communication, professionalism and physical exam. I am focused on curriculum design and innovation, having helped develop the Continuity of Care Clerkship, the clinical skills curriculum in Practice of Medicine, the Family Medicine core clerkship, outpatient faculty development modules and the SHIELD course (Stanford Healthcare Innovations and Experiential Learning Directive).

  • Ingela Schnittger, MD

    Ingela Schnittger, MD

    Professor of Medicine (Cardiovascular)

    Current Research and Scholarly Interests My main research continues to be in the field of echocardiography. Several areas of research are currently being pursued.

  • Donald Schreiber

    Donald Schreiber

    Associate Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests My research group focuses on the diagnosis and treatment of cardiovascular emergencies including acute myocardial infarction, acute coronary syndrome and congestive heart failure. We have evaluated novel cardiac markers and point-of-care testing in clinical practice. Current projects also include the diagnosis and treatment of acute pulmonary embolism and deep venous thrombosis. Other interests include spinal cord injury, pneumonia and sepsis.

  • John S. Schroeder, MD

    John S. Schroeder, MD

    Professor (Clinical) of Medicine (Cardiovascular)

    Current Research and Scholarly Interests 1. Clinical Pharmocology of Cardiovascular Drugs
    (a) Calcium Channel Blockers
    (b) Agents for Heart Failure
    (c) Anti-atherosclerotic Effects of Cardiovascular Drugs, e.g. Calcium Channel Blockers

    2. Cardiac Transplantation/Congestive Heart Failure

    3. Coronary Artery Spasm

  • Matthew P. Scott

    Matthew P. Scott

    Professor of Developmental Biology, Emeritus

    Current Research and Scholarly Interests Our research has been focused on the genetic regulation of animal development and its relation to birth defects, cancer, and neurodegeneration. We studied mechanisms and functions of Hedgehog (Hh) signaling, which controls cell fates and growth, in the context of normal development and brain cancer. We studied a neurodegenerative disease, Niemann-Pick C syndrome, that affects intracellular organelle movements and sterol homeostasis. Due to Dr. Scott's new job, the lab is no longer active.

  • Katharine Edwards

    Katharine Edwards

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Potential impact of brief behavioral interventions to improve adjustment, coping, medical adherence, and cardiovascular health among cardiac patients.

    Psychosocial challenges of patients with spontaneous coronary artery dissection (SCAD).

    Assessment and training in evidence-based psychological therapies.

  • Vittorio Sebastiano

    Vittorio Sebastiano

    Assistant Professor (Research) of Obstetrics and Gynecology (Reproductive and Stem Cell Biology)

    Current Research and Scholarly Interests The thread of Ariadne that connects germ cells, preimplatation development and pluripotent stem cells is the focus of my research, with a specific interest in human development. My long-term goals are: 1. Understanding the biology of germ cells and and their ability to sustain early preimplantation development; 2. Understanding the mechanisms that regulate very early cell fate decisions in human embryos; 3. Understanding the biology of derivation and maintenance of Pluripotent Stem Cells

  • George Segall

    George Segall

    Professor of Radiology and, by courtesy, of Medicine (Cardiovascular)

    Current Research and Scholarly Interests Scintigraphic evaluation of coronary blood flow and myocardial function using single photon emission computed tomography (SPECT) and positron emission tomography (PET). Tumor imaging and characterization of pulmonary nodules with PET/CT.

  • Zachary M. Sellers, MD, PhD

    Zachary M. Sellers, MD, PhD

    Assistant Professor of Pediatrics (Gastroenterology)

    Bio I am a pediatric physician-scientist striving to advance cystic fibrosis clinical care and translational research. Clinically, I am focused on gastrointestinal manifestations of cystic fibrosis, developing diagnostic and therapeutic modalities to improve the gastrointestinal and liver health of those with cystic fibrosis. I also specialize in the clinical management of pediatric pancreatitis and am involved with the international INSPPIRE consortium to study pediatric pancreatitis. My research spans the entire spectrum across basic science and translational research to clinical research and trials. In the laboratory, my projects are centered around understanding mechanisms of ion transport in cystic fibrosis tissues and determining how loss of CFTR ion transport leads to pathologic changes in human physiology. We are also very interested in the pathophysiological relationship between pancreatitis and intestinal diseases, such as inflammatory bowel disease. Our laboratory has expertise in epithelial ion transport, with specialized skills in the measurement of bicarbonate transport. We are also part of a Multi-PI collaboration pursuing CFTR gene editing and stem cell engraftment for the treatment of cystic fibrosis. We utilize a combination of immortalized and primary cell culture, organoids, mouse and human tissue, and whole animal in vivo studies.

  • Nigam H. Shah, MBBS, PhD

    Nigam H. Shah, MBBS, PhD

    Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science

    Current Research and Scholarly Interests We analyze multiple types of health data (EHR, Claims, Wearables, Weblogs, and Patient blogs), to answer clinical questions, generate insights, and build predictive models for the learning health system.

  • Andrew Young Shin

    Andrew Young Shin

    Clinical Professor, Pediatrics - Cardiology

    Current Research and Scholarly Interests SURF PROGRAM
    The SURF program is an innovative collaboration between LPCH, Stanford University Hospital and the Stanford School of Engineering. The program has focused on improving quality and safety of patient care, improving hospital operations and promoting clinical effectiveness utilizing contemporary technologies such as machine learning, mathematical optimization, simulation and a variety of statistical, probabilistic and computational tools. The program has 2 independent funding mechanism to primarily improve patient care/hospital operations and improve academics for faculty within the department of Pediatrics at LPCH.

    https://surf.stanford.edu/


    CLINICAL EFFECTIVENESS
    The Clinical Effectiveness (CE) Program is a funded program that aims to understand and improve unnecessary variation in healthcare delivery in order to optimize quality of care and reduce wasteful expenditures. The CE program has developed innovative programs such as Target Based Care, an award-winning intervention to reduce variation in hospital length of stay and currently a multi-center trial involving more than 20 hospitals in North America. In 2016, the CE program included the first CE fellowship program in a pediatric training program with 3 cycles of graduates. The CE program is supported by LPCH and a philanthropic gift by Susan Choe and Thomas Tobiason.

  • Judith Shizuru

    Judith Shizuru

    Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and of Pediatrics (Stem Cell Transplantation)

    Current Research and Scholarly Interests Transplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.

  • Joseph Shrager

    Joseph Shrager

    Professor of Cardiothoracic Surgery

    Current Research and Scholarly Interests In clinical research, Dr. Shrager has been an innovator studying outcomes in a variety of areas within Thoracic Surgery including: parenchyma-sparing operations and minimally invasive resections for lung cancer, transcervical thymectomy for myasthenia gravis, and surgical treatment of emphysema.

    In the lab, Dr. Shrager is focused on the impact of disease states upon the diaphragm. His group published the seminal paper (NEJM) describing diaphragm atrophy assoc'd with mechanical ventilation.

  • Yasuhiro Shudo, MD, PhD

    Yasuhiro Shudo, MD, PhD

    Clinical Assistant Professor, Cardiothoracic Surgery

    Bio Dr. Shudo is a board-certified cardiothoracic surgeon and clinical assistant professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.

    His clinical focus is the surgical treatment of end-stage cardiopulmonary failure, including heart transplant, heart-lung transplant, lung transplant, mechanical circulatory support (MCS), and extracorporeal membrane oxygenation (ECMO). He has published numerous landmark papers
    and chapters.

    Dr. Shudo also performs mitral valve repair/replacement (MVR), aortic valve replacement (AVR), complex valve surgery, coronary artery bypass graft (CABG) surgery, reoperative cardiac surgery, minimally invasive surgery, and transcatheter aortic valve replacement (TAVR).

    Dr. Shudo is fully committed to innovative, comprehensive, and compassionate care for each patient he treats.

  • Julia Fridman Simard

    Julia Fridman Simard

    Associate Professor of Epidemiology and Population Health and, by courtesy, of Medicine (Immunology & Rheumatology)

    Bio Julia Fridman Simard, ScD, is an Associate Professor of Epidemiology & Population Health, and, by courtesy, of Medicine in Immunology and Rheumatology at Stanford University School of Medicine.

    Dr. Simard earned her Masters and Doctorate of Science in Epidemiology degrees at the Harvard School of Public Health. During that time she trained with investigators at the Section of Clinical Sciences, Division of Rheumatology, Immunology, and Allergy at Brigham and Women?s Hospital and the Cardiovascular Epidemiology Research Unit at Beth Israel Deaconess Medical Center. In 2008, Dr. Simard relocated to Sweden to begin a Postdoctoral Fellowship in Clinical Epidemiology at the Karolinska Institutet in Stockholm. She became an Assistant Professor in their Clinical Epidemiology Unit in 2011, and was later honored with a Karolinska Institutet Teaching Award. Leveraging the population-based registers of Sweden, Dr. Simard initiated a national register linkage study to examine the utility of registers in Systemic Lupus Erythematosus (SLE) research and develop an extensive data repository for future epidemiologic investigations.

    While maintaining a close collaboration with the Karolinska Institutet, she joined Stanford?s Epidemiology faculty in 2013. Dr. Simard studies outcomes such as malignancy, stroke, infection, and mortality, in patients with systemic autoimmune rheumatic diseases with a focus on systemic lupus erythematosus. Recently her primary research focus has shifted to the intersection between reproductive epidemiology and rheumatic disease fueled by a K01 career development award from the NIH (NIAMS) to study maternal and fetal outcomes in systemic lupus pregnancy. This led to collaborations with colleagues at Stanford, throughout the US, and abroad, and a series of projects focused on the diagnosis of preeclampsia and associated risks in pregnant women with systemic lupus. Dr. Simard was awarded a Peter Joseph Pappas Research Grant from the Preeclampsia Foundation for her lab's work examining preeclampsia risk in high-risk populations, and a McCormick Faculty Award from Stanford Medicine to take important steps towards disentangling preeclampsia from lupus nephritis. Dr. Simard is leading an international study of hydroxychloroquine in lupus pregnancy leveraging mixed methods in partnership with qualitative researchers, patients, clinicians, and epidemiologists in Sweden, Canada, and in the United States.

    In addition to these issues of misclassification in reproductive rheumatology questions, Dr. Simard's lab is also interested in how misclassification, missed opportunities, and misdiagnosis contribute to disparities in complex conditions such as systemic lupus. In addition to methodologic issues around misclassification and bias and the largely clinical epidemiology focus of her work, Dr. Simard's work examines social determinants of health and health disparities. Dr. Simard was recently awarded an R01 from NIH (NIAID) to study the role of cognitive and unconscious bias in clinical decision making for female-predominant diseases including lupus.

  • Robert Simoni

    Robert Simoni

    Professor, Biology

    Current Research and Scholarly Interests Cholesterol in biological membranes; genetic mechanisms & cholesterol production

  • Michael Snyder

    Michael Snyder

    Stanford W. Ascherman, MD, FACS, Professor of Genetics

    Current Research and Scholarly Interests Our laboratory use different omics approaches to study a) regulatory networks, b) intra- and inter-species variation which differs primarily at the level of regulatory information c) human health and disease. For the later we have established integrated Personal Omics Profiling (iPOP), an analysis that combines longitudinal analyses of genomic, transcriptomic, proteomic, metabolomic, DNA methylation, microbiome and autoantibody profiles to monitor healthy and disease states

  • Edda Spiekerkoetter

    Edda Spiekerkoetter

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly Interests Pulmonary Arterial Hypertension
    Pulmonary Vascular Remodeling
    Modulation of BMP signaling
    BMP signaling in health and disease in the right ventricle of the heart
    "BMP signature" in blood as a biomarker
    BMP signaling in neonatal chronic lung disease

  • Joshua M. Spin

    Joshua M. Spin

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Dr. Spin began his research career studying the structural biology of low density lipoprotein, and has been augmenting his skills with intensive training in molecular biology techniques, particularly those involving high-throughput genetic expression profiling. He is especially interested in vascular smooth muscle cells, and the role of smooth muscle differentiation and phenotypic switching in development and vascular disease. His latest work has focused on the biology of aortic aneurysms.

  • James Spudich

    James Spudich

    Douglass M. and Nola Leishman Professor of Cardiovascular Disease

    Current Research and Scholarly Interests The general research interest of this laboratory is the molecular basis of cell motility, with a current emphasis on power output by the human heart. We have three specific research interests, the molecular basis of energy transduction that leads to ATP-driven myosin movement on actin, the biochemical basis of the regulation of actin and myosin interaction and their assembly states, and the roles these proteins play in vivo, in cell movement, changes in cell shape and muscle contraction.

  • Marcia L. Stefanick, Ph.D.

    Marcia L. Stefanick, Ph.D.

    Professor (Research) of Medicine (Stanford Prevention Research Center), of Obstetrics and Gynecology and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly Interests Marcia L. Stefanick, Ph.D is a Professor of Medicine Professor of Obstetrics and Gynecology, and by courtesy, Professor of Epidemiology and Population Health at Stanford University School of Medicine. Dr. Stefanick?s research focuses on chronic disease prevention (particularly, heart disease, breast cancer, osteoporosis, and dementia) in both women and men. She is currently the Principal Investigator the Women?s Health Initiative (WHI) Extension Study, having been the PI of the Stanford Clinical Center of the landmark WHI Clinical Trials and Observational Study since 1994 and Chair of the WHI Steering and Executive Committees from 1998-2011, as well as PI of the WHI Strong and Healthy (WHISH) Trial which is testing the hypothesis that a DHHS-based physical activity intervention, being delivered to a multi-ethnic cohort of about 24,000 WHI participants across the U.S., aged 68-99 when the trial started in 2015, will reduce major cardiovascular events over 8 years, compared to an equal number of ?usual activity? controls. Dr. Stefanick is also PI of the Osteoporotic Study of Men (MrOS) which is continuing to conduct clinical assessments of bone and body composition in survivors of an original cohort of nearly 6000 men aged 65 and over in 2001. As founding Director of the Stanford Women?s Health and Sex Differences in Medicine (WHSDM, ?wisdom?) Center, she plays a major role in promoting research and teaching on Sex and Gender in Human Physiology and Disease, Women?s Health and Queer Health and Medicine. Dr. Stefanick also plays major leadership roles at the Stanford School of Medicine, including as co-leader of the Population Sciences Program of the Stanford Cancer Institute, Stanford?s NCI-funded comprehensive cancer center.

    Dr. Stefanick obtained her B.A. in biology from the University of Pennsylvania, Philadelphia, PA (1974), then pursued her interest in hormone and sex difference research at the Oregon Regional Primate Research Center, after which she obtained her PhD in Physiology at Stanford University, focusing on reproductive physiology and neuroendocrinology, with exercise physiology as a secondary focus. Her commitment to human research led to a post-doctoral fellowship in Cardiovascular Disease Prevention at the Stanford Prevention Research Center, which has been her academic home for nearly 40 years.

  • Lars Steinmetz

    Lars Steinmetz

    Professor of Genetics

    Current Research and Scholarly Interests We apply diverse genomic approaches to understand how genetic variation affects health and disease by: 1) functional and mechanistic analyses of gene regulation, 2) studies of meiotic recombination and inheritance, 3) analyses of genetic and environmental interactions, and 4) characterization of diseases in human cells and model organisms. We integrate wet lab and computational genomic, transcriptomic, proteomic and metabolic approaches, and develop technologies to enable personalized medicine.

  • Jordan Stern

    Jordan Stern

    Clinical Assistant Professor, Surgery - Vascular Surgery

    Bio Dr. Stern earned his medical degree at The Ohio State University College of Medicine in 2008. He completed his general surgery residency at The University of Chicago in 2015, which included a two-year research fellowship in Translational Systems Biology. He then completed his vascular and endovascular surgery fellowship at New York-Presbyterian Hospital, Columbia University Medical Center/Weill Cornell Medicine, in 2017. Dr. Stern is board certified in both general surgery and vascular surgery.

    Dr. Stern joined Stanford Vascular Surgery in 2017 as a Clinical Assistant Professor of Surgery. His primary practice is at Stanford Health Care.

    Dr. Stern?s clinical and academic interests are in the treatment of aortic disease. He is involved in the development of novel treatment strategies for complex aortic pathologies, and serves as principal investigator on several clinical trials. He is also involved in clinical research, examining contemporary practice patterns and outcomes from endovascular and open surgical interventions.

  • Simon H. Stertzer, MD, FACC,FAHA,FACP

    Simon H. Stertzer, MD, FACC,FAHA,FACP

    Professor of Medicine (Cardiovascular) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests Coronary Angioplasty; Intramyocardial Stem cell delivery

  • Frank E. Stockdale

    Frank E. Stockdale

    Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus

    Current Research and Scholarly Interests Laboratory and clinical research in breast cancer ; Normal and abornal differentiation and growth

  • Ga Young Suh

    Ga Young Suh

    Adjunct Professor, Surgery - Vascular Surgery

    Bio After completion of MS/PhD from Mechanical Engineering, I've been with Division of Vascular Surgery at Stanford since 2011. I am motivated to apply Engineering-based techniques to patient anatomy or medical device. Also, I am actively teaching and training undergrad students, medical school students and trainees.

  • Katrin J Svensson

    Katrin J Svensson

    Assistant Professor of Pathology

    Current Research and Scholarly Interests Molecular metabolism
    Protein biochemistry
    Cell biology and function
    Animal physiology

  • James Swartz

    James Swartz

    James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering

    Current Research and Scholarly Interests Program Overview

    The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
    Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
    To advance human health we focus on: a) achieving the 120 year-old dream of producing ?magic bullets?; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
    To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
    More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, ?non-natural? objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances.

  • Daniel Sze, MD, PhD

    Daniel Sze, MD, PhD

    Professor of Radiology (Interventional Radiology)

    Current Research and Scholarly Interests Transarterial administration of chemotherapeutics, radioactive microspheres, and biologics for the treatment of unresectable tumors; management of portal hypertension and complications of cirrhosis (TIPS); treatment of complications of organ transplantation; Venous and pulmonary arterial thrombolysis and reconstruction; Stent and Stent-graft treatment of peripheral vascular diseases, aneurysms, aortic dissections

  • C. Barr Taylor

    C. Barr Taylor

    Professor of Psychiatry and Behavioral Sciences, Emeritus

    Current Research and Scholarly Interests Dr. Taylor is developing and evaluating innovative electronic and computer-assisted programs to make treatments, proven effective for treating various lifestyle and psychosocial problems, more cost-effective and available. He is also developing new models of evidence-based psychiatry care for eating, anxiety and depressive disorders.

Stanford Medicine Resources: